ASHP will provide progress updates on a routine basis and is certainly scheduled to provide the FDA with last standardized lists for adult-based IV continuous infusions and for compounded oral liquid medicines by March 30, 2016.. PRESS RELEASE BETHESDA, MD – the meals and Drug Administration provides awarded ASHP a three-year agreement to develop and implement national standardized concentrations for intravenous and oral liquid medicines. The contract is part of FDA’s Safe and sound Use Initiative, an effort to reduce preventable harm from medications by creating and facilitating open public and private collaborations within the health care community.Researchers at CSIRO Plant Sector are using RNAi to modify the essential oil composition in cotton seed and create other novel traits. A respected conference loudspeaker, CSIRO Plant Industry’s Dr Peter Waterhouse, was a member of the study team which, in 1995, first demonstrated gene silencing in plants by intentionally using double-stranded RNA. Waterhouse and his colleague, Dr Chris Helliwell, will speak on the mechanisms and applications of RNAi in plant genomics. Related StoriesRNA-based drugs provide many advantages over CRISPR/Cas9 gene editing systemPerisylvian polymicrogyria gene foundMU researchers successfully treat dogs with DMD, arrange for human clinical trialsInternational speakers add a Post-doctoral Fellow at the Massachusetts Institute of Technology’s Center for Cancer Study, Dr Carl Novina.